Summit Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Florida, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
601 Brickell Key Dr Ste 1000, Miami, Flo...Phone Number
(650) 382-0001Website
www.smmttx.comRevenue
-Stock Symbol
SMMTIndustry
About Summit Therapeutics
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC.Explore more
Summit Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Summit Therapeutics
Compare insights from companies similar to Summit Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Summit Therapeutics
201-500
Public
$2.7B
2003
RM
Rishma MerchantSenior Director and Chief of Staff, Clinical Operations
Summit Therapeutics Tech Stack
A closer look at the technologies used by Summit Therapeutics
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Summit Therapeutics
Sign Up For FreeTo access detailed company insights
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of n... Read More
